VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10006502 | HBV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS30017091 | HIV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20010110 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20067968 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
TVIS20032707 | HPV | ENSG00000138039.15 | protein_coding | LHCGR | No | No | 3973 | P22888 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | LHCGR |
---|---|
DrugBank ID | DB00050 |
Drug Name | Cetrorelix |
Target ID | BE0000134 |
UniProt ID | P22888 |
Regulation Type | |
PubMed IDs | 17139284; 17016423; 11943741 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Ascoli M, Fanelli F, Segaloff DL: The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002 Apr;23(2):141-74. |
Groups | Approved; Investigational |
Direct Classification | Polypeptides |
SMILES | CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O |
Pathways | |
PharmGKB | PA164764506 |
ChEMBL | CHEMBL1200490 |